NO843181L - Misbrukt drogeproeveindikatoranordning og fremgangsmaate ved fremstilling av denne - Google Patents
Misbrukt drogeproeveindikatoranordning og fremgangsmaate ved fremstilling av denneInfo
- Publication number
- NO843181L NO843181L NO843181A NO843181A NO843181L NO 843181 L NO843181 L NO 843181L NO 843181 A NO843181 A NO 843181A NO 843181 A NO843181 A NO 843181A NO 843181 L NO843181 L NO 843181L
- Authority
- NO
- Norway
- Prior art keywords
- solution
- matrix
- paper
- test
- sample
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 238000003255 drug test Methods 0.000 title description 8
- 239000003814 drug Substances 0.000 claims abstract description 83
- 229940079593 drug Drugs 0.000 claims abstract description 82
- 239000011159 matrix material Substances 0.000 claims abstract description 53
- 239000000126 substance Substances 0.000 claims abstract description 37
- 229940125717 barbiturate Drugs 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 24
- 230000035945 sensitivity Effects 0.000 claims abstract description 24
- 239000003204 tranquilizing agent Substances 0.000 claims abstract description 18
- 230000002936 tranquilizing effect Effects 0.000 claims abstract description 18
- 210000001124 body fluid Anatomy 0.000 claims abstract description 14
- 239000010839 body fluid Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 238000012360 testing method Methods 0.000 claims description 92
- 239000000243 solution Substances 0.000 claims description 79
- 239000000523 sample Substances 0.000 claims description 48
- 238000006243 chemical reaction Methods 0.000 claims description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- 239000012488 sample solution Substances 0.000 claims description 28
- 230000003533 narcotic effect Effects 0.000 claims description 25
- 239000003086 colorant Substances 0.000 claims description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 18
- 238000007654 immersion Methods 0.000 claims description 17
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 229940025084 amphetamine Drugs 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 claims description 11
- WDJPBIRJSVMEKJ-UHFFFAOYSA-N 1-anilino-3-phenyliminourea;1,3-dianilinourea Chemical compound C=1C=CC=CC=1NNC(=O)NNC1=CC=CC=C1.C=1C=CC=CC=1N=NC(=O)NNC1=CC=CC=C1 WDJPBIRJSVMEKJ-UHFFFAOYSA-N 0.000 claims description 10
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical group C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- HWSISDHAHRVNMT-UHFFFAOYSA-N Bismuth subnitrate Chemical compound O[NH+]([O-])O[Bi](O[N+]([O-])=O)O[N+]([O-])=O HWSISDHAHRVNMT-UHFFFAOYSA-N 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 8
- 239000002250 absorbent Substances 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 8
- 229960001482 bismuth subnitrate Drugs 0.000 claims description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 8
- 239000004081 narcotic agent Substances 0.000 claims description 7
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 6
- 238000004320 controlled atmosphere Methods 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 150000003057 platinum Chemical class 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- 239000012085 test solution Substances 0.000 claims description 2
- 229910021592 Copper(II) chloride Inorganic materials 0.000 claims 2
- 230000005070 ripening Effects 0.000 claims 2
- 238000005494 tarnishing Methods 0.000 claims 2
- 239000006103 coloring component Substances 0.000 claims 1
- 238000000203 droplet dispensing Methods 0.000 claims 1
- 238000005470 impregnation Methods 0.000 claims 1
- KOECRLKKXSXCPB-UHFFFAOYSA-K triiodobismuthane Chemical compound I[Bi](I)I KOECRLKKXSXCPB-UHFFFAOYSA-K 0.000 claims 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract description 20
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract description 12
- 229960003920 cocaine Drugs 0.000 abstract description 10
- 238000004809 thin layer chromatography Methods 0.000 abstract description 10
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 239000003456 ion exchange resin Substances 0.000 abstract description 8
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 8
- 230000008859 change Effects 0.000 abstract description 6
- 229960005181 morphine Drugs 0.000 abstract description 6
- 238000010186 staining Methods 0.000 abstract description 6
- -1 dilauder Chemical compound 0.000 abstract description 4
- 239000012128 staining reagent Substances 0.000 abstract description 3
- 239000000123 paper Substances 0.000 description 184
- 210000002700 urine Anatomy 0.000 description 66
- 239000000203 mixture Substances 0.000 description 49
- 238000009472 formulation Methods 0.000 description 48
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 24
- 239000003640 drug residue Substances 0.000 description 18
- 230000009257 reactivity Effects 0.000 description 18
- 229960001797 methadone Drugs 0.000 description 17
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 14
- 238000001035 drying Methods 0.000 description 14
- 229930013930 alkaloid Natural products 0.000 description 12
- 229910052697 platinum Inorganic materials 0.000 description 12
- 208000011117 substance-related disease Diseases 0.000 description 12
- 206010013654 Drug abuse Diseases 0.000 description 11
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 11
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 10
- 229910052797 bismuth Inorganic materials 0.000 description 9
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 9
- 238000005554 pickling Methods 0.000 description 9
- 229940099212 dilaudid Drugs 0.000 description 7
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 7
- 229960002523 mercuric chloride Drugs 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000011835 investigation Methods 0.000 description 6
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 5
- 229960004126 codeine Drugs 0.000 description 5
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 5
- 229960002715 nicotine Drugs 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 238000003677 abuse test Methods 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229960002069 diamorphine Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 229960003529 diazepam Drugs 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000012113 quantitative test Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 210000001138 tear Anatomy 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 229940125725 tranquilizer Drugs 0.000 description 2
- ZFWAHZCOKGWUIT-UHFFFAOYSA-N 1-anilino-3-phenyliminourea Chemical compound C=1C=CC=CC=1N=NC(=O)NNC1=CC=CC=C1 ZFWAHZCOKGWUIT-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- RXPAJWPEYBDXOG-UHFFFAOYSA-N hydron;methyl 4-methoxypyridine-2-carboxylate;chloride Chemical compound Cl.COC(=O)C1=CC(OC)=CC=N1 RXPAJWPEYBDXOG-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- ZXDJCKVQKCNWEI-UHFFFAOYSA-L platinum(2+);diiodide Chemical group [I-].[I-].[Pt+2] ZXDJCKVQKCNWEI-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000006308 propyl amino group Chemical class 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44783582A | 1982-12-08 | 1982-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO843181L true NO843181L (no) | 1984-08-08 |
Family
ID=23777937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO843181A NO843181L (no) | 1982-12-08 | 1984-08-08 | Misbrukt drogeproeveindikatoranordning og fremgangsmaate ved fremstilling av denne |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0128937A1 (es) |
| JP (1) | JPS60500511A (es) |
| AU (1) | AU2347984A (es) |
| DE (1) | DE3390377T1 (es) |
| ES (1) | ES8503854A1 (es) |
| FI (1) | FI843113A (es) |
| FR (1) | FR2537724A1 (es) |
| GB (1) | GB2146429A (es) |
| IL (1) | IL70391A0 (es) |
| IT (1) | IT1167682B (es) |
| NL (1) | NL8320408A (es) |
| NO (1) | NO843181L (es) |
| PT (1) | PT77790B (es) |
| SE (1) | SE8403999L (es) |
| WO (1) | WO1984002397A1 (es) |
| ZA (1) | ZA839075B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844866A (en) * | 1984-11-13 | 1989-07-04 | Matrix Technologies, Inc. | Carrier for detecting drug abuse compounds |
| EP0201586A1 (en) * | 1984-11-16 | 1986-11-20 | Med-Tech Products, Inc. | Process for the preparation of a bibulous reactive medium |
| US4752448A (en) * | 1985-12-18 | 1988-06-21 | Keystone Diagnostics, Inc. | Drug abuse test paper |
| IL77871A (en) * | 1986-02-12 | 1990-07-26 | Baruch Glattstein | Process and kit for detecting cocaine or heroin utilizing a sulfonated aromatic ph indicator |
| US5085988A (en) * | 1986-09-05 | 1992-02-04 | Syntex (U.S.A.) Inc. | Immunoseparating strip |
| US4963468A (en) * | 1986-09-05 | 1990-10-16 | Syntex (U.S.A.) Inc. | Immunoseparating strip |
| US4959307A (en) * | 1986-09-05 | 1990-09-25 | Syntex (U.S.A.) Inc. | Immunoseparating strip |
| US4806487A (en) * | 1987-05-29 | 1989-02-21 | Analytical Innovations, Inc. | Basic drug detection method |
| US4816415A (en) * | 1987-05-29 | 1989-03-28 | Analytical Innovations, Inc. | Cannabinoid detection method |
| US9759733B1 (en) | 2016-04-08 | 2017-09-12 | Michael D. Callahan | Mass produced, low cost, portable test kit for the detection and identification of narcotics |
| KR102665445B1 (ko) * | 2021-11-24 | 2024-05-10 | 성균관대학교산학협력단 | 마약검출용 키트, 이의 제조방법 및 이를 이용한 마약의 검출방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3438737A (en) * | 1965-10-01 | 1969-04-15 | Miles Lab | Protein test composition,device and method |
| US3723064A (en) * | 1971-07-26 | 1973-03-27 | L Liotta | Method and device for determining the concentration of a material in a liquid |
| GB1361964A (en) * | 1972-02-04 | 1974-07-30 | Orion Yhtymae Oy | Means for isolation and detection of barbituric acid derivatives and glutehimide in biological fluids |
| BE795221A (fr) * | 1972-02-12 | 1973-08-09 | Merck Patent Gmbh | Procede et reactif rapide en vue de deceler des stupefiants |
| GB1426177A (en) * | 1972-04-07 | 1976-02-25 | Secretary Trade Ind Brit | Detection of drugs |
| ZA733611B (en) * | 1972-10-11 | 1974-04-24 | Merck Patent Gmbh | Indicator for the determination of urea |
| US3915639A (en) * | 1973-10-18 | 1975-10-28 | Robert M Friedenberg | Drug abuse dipstick |
| US3912655A (en) * | 1973-12-26 | 1975-10-14 | American Cyanamid Co | Reagent impregnated paper strips for use in preparing TLC spray reagents |
| US3901657A (en) * | 1974-04-29 | 1975-08-26 | Sun Scient Inc | Device for testing solutions and body fluids |
| US4110078A (en) * | 1976-11-26 | 1978-08-29 | Zelonis Paul Thomas | Binary reagent system for detecting drugs of abuse |
-
1983
- 1983-12-06 IL IL70391A patent/IL70391A0/xx unknown
- 1983-12-06 ZA ZA839075A patent/ZA839075B/xx unknown
- 1983-12-06 IT IT24086/83A patent/IT1167682B/it active
- 1983-12-07 GB GB08419898A patent/GB2146429A/en not_active Withdrawn
- 1983-12-07 WO PCT/US1983/001920 patent/WO1984002397A1/en active Application Filing
- 1983-12-07 NL NL8320408A patent/NL8320408A/nl unknown
- 1983-12-07 DE DE19833390377 patent/DE3390377T1/de not_active Withdrawn
- 1983-12-07 PT PT77790A patent/PT77790B/pt unknown
- 1983-12-07 AU AU23479/84A patent/AU2347984A/en not_active Abandoned
- 1983-12-07 ES ES527904A patent/ES8503854A1/es not_active Expired
- 1983-12-07 JP JP59500308A patent/JPS60500511A/ja active Pending
- 1983-12-07 EP EP84900245A patent/EP0128937A1/en not_active Withdrawn
- 1983-12-08 FR FR8319638A patent/FR2537724A1/fr not_active Withdrawn
-
1984
- 1984-08-07 SE SE8403999A patent/SE8403999L/ not_active Application Discontinuation
- 1984-08-08 FI FI843113A patent/FI843113A/fi not_active Application Discontinuation
- 1984-08-08 NO NO843181A patent/NO843181L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2347984A (en) | 1984-07-05 |
| WO1984002397A1 (en) | 1984-06-21 |
| FI843113A0 (fi) | 1984-08-08 |
| IT1167682B (it) | 1987-05-13 |
| ES527904A0 (es) | 1985-03-16 |
| IT8324086A1 (it) | 1985-06-06 |
| JPS60500511A (ja) | 1985-04-11 |
| FR2537724A1 (en) | 1984-06-15 |
| SE8403999D0 (sv) | 1984-08-07 |
| SE8403999L (sv) | 1984-08-07 |
| GB2146429A (en) | 1985-04-17 |
| PT77790B (en) | 1986-03-20 |
| ZA839075B (en) | 1985-07-31 |
| FI843113A (fi) | 1984-08-08 |
| GB8419898D0 (en) | 1984-09-05 |
| DE3390377T1 (de) | 1985-01-10 |
| PT77790A (en) | 1984-01-01 |
| EP0128937A1 (en) | 1984-12-27 |
| NL8320408A (nl) | 1984-11-01 |
| IT8324086A0 (it) | 1983-12-06 |
| IL70391A0 (en) | 1984-03-30 |
| ES8503854A1 (es) | 1985-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3915639A (en) | Drug abuse dipstick | |
| US4752448A (en) | Drug abuse test paper | |
| US20160077013A1 (en) | Laminated Detector for Detection and Quantitative Determination of Formaldehyde | |
| JP2002372524A (ja) | 水性液体試料中のアミンの検査器具および膣感染症の診断への応用 | |
| NO843181L (no) | Misbrukt drogeproeveindikatoranordning og fremgangsmaate ved fremstilling av denne | |
| US5726062A (en) | Method of detecting protein and a kit detecting protein using the same | |
| US7067320B2 (en) | Sensor for luminescense-optical determination of an analyte | |
| US5565363A (en) | Reagent composition for measuring ionic strength or specific gravity of aqueous solution samples | |
| JP2519102B2 (ja) | 水性液を比重に関して試験するための組成物及び方法 | |
| CA2986746A1 (en) | Indicator panels for incontinence products | |
| WO2014067033A1 (zh) | 一种检测宫颈渗液血红素的方法及检测盒 | |
| JPH0266451A (ja) | 尿のイオン強度又は比重を測定する方法、試薬及び試験片 | |
| EP0041175B1 (en) | Ion specific analytical element | |
| JPH0159536B2 (es) | ||
| CA2001477A1 (en) | Quick color test to detect lead release from glazed ceramic and enameled metal ware | |
| JPH09145711A (ja) | 尿中タンパク質を検出するための試験片 | |
| JPH05196616A (ja) | 水性液体試料のイオン強度又は比重測定用試薬組成物 | |
| US2676874A (en) | Method of and means for the rapid approximate quantitative estimation of chloride concentration in aqueous liquids | |
| TWI489096B (zh) | 具有線狀傳導功能的檢測裝置及其應用 | |
| EP0620437B1 (en) | Multilayer test strip | |
| Giri et al. | Circular paper chromatographic method for estimation of thiamine and riboflavin in multivitamin preparations | |
| JPH0921809A (ja) | 蛋白質検出用分析素子、蛋白質の測定方法及び検出媒体 | |
| Tavallali et al. | Design and Evaluation of a Mercury (II) Optode Based on Immobilization of 1-(2-Pyridylazo)-2-Naphthol on a Triacetylcellulose Membrane and Determination in Various Samples. | |
| WO2020014945A1 (zh) | 一种便携式取液装置 | |
| Fischl et al. | Rapid spot tests for routine urine analysis |